Resources

Ce rapport est fait pour informer des décisions futures des partenaires qui travaillent en Afrique avec le programme USAID’s Act to End Neglected Tropical Diseases (NTDs) | West (Act |West) ou même pour les African Neglected Tropical Disease Programs (NTDPs) qui veulent adopter ces plateformes technologiques de Collecte Electronique de données (EDC) pour faire des Enquêtes Spécifiques des Maladies (DSA) mais qui ont besoin de plus des informations avant de commencer.

This report is intended to inform future decisions by Africa-based implementing partners within USAID’s Act to End Neglected Tropical Diseases (NTDs) | West (Act | West) and African Neglected Tropical Disease Programs (NTDPs) who wish to adopt EDC platforms for upcoming DSAs but require more information before doing so.

Adverse events (AEs) particularly severe adverse events (SAEs) during and following mass drug administration have a serious effect not only on the people who are affected directly, but also on the viability of the MOH’s national NTD control program.

Trachoma baseline surveys, trachoma impact surveys, trachoma surveillance surveys, and trichiasis-only surveys are key disease-specific assessments of trachoma elimination programs, used to start mass drug administration (MDA), monitor progress, decide when to stop MDA, and inform attainment of elimination of trachoma as a public health problem.

This report outlines the key achievements and challenges in the first six months of the second year of implementation of USAID's Act to End NTDs | West Program, spanning the period October 1, 2019–March 31, 2020.

This resource document complements the World Health Organization’s (WHO’s) guidance for NTD programs released on July 27, 2020.

Cette brochure résume le travail de la loi de l'USAID pour mettre fin aux MTN | Programme Ouest, qui donne une vue d’ensemble des activités du programme et des progrès accomplis à ce jour alors que nous continuons à prendre des mesures pour perturber les dommages causés par les maladies débilitantes de la pauvreté. Construit sur la base d'une large coopération internationale et mis en œuvre par un consortium solide de partenaires profondément engagés, dirigé par FHI 360, Act | West travaille en étroite collaboration avec les gouvernements de 11 pays africains pour éliminer et contrôler à long terme cinq des MTN les plus courantes au monde.

This brochure summarizes the work of USAID's Act to End NTDs | West Program, providing a big picture look at program activities and progress to date as we continue taking action to disrupt the damage of debilitating diseases of poverty. Built on a foundation of broad international cooperation and implemented by a strong consortium of deeply committed partners, led by FHI 360, Act | West works closely with the governments of 11 African countries to eliminate and control five of the world’s most common NTDs over the long term.

The economic impact model and supporting disease-specific tools estimate the direct and indirect economic impact, efficiencies, and societal benefits of investing in NTD programs and interventions. The workshop will explain how NTD programs can use the supporting tools to develop investment cases to advocate for domestic resources and prioritize NTD investments in a multi-disease environment. It will also describe how, with support from HKI and Deloitte, Sierra Leone’s NTD program will pilot these tools and serve as the advisor on country needs, program and financial data, user testing of the tools, and utilization of the outputs for advocacy. After incorporating the feedback from the pilot in Sierra Leone, the Act | West team will make the tools available to all supported countries to create investment cases that enhance advocacy efforts for domestic resource mobilization for NTD programming.

The Carter Center's Emily Griswold presents on improving mass drug administration tools on January 16, 2020.